High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.

<h4>Background</h4>High-risk human papillomavirus HPV (HR-HPV) modifies cervical cancer risk in people living with HIV, yet African populations are under-represented. We aimed to compare the frequency, multiplicity and consanguinity of HR-HPVs in HIV-negative and HIV-positive Zimbabwean...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Oppah Kuguyo, Racheal S Dube Mandishora, Nicholas Ekow Thomford, Rudo Makunike-Mutasa, Charles F B Nhachi, Alice Matimba, Collet Dandara
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/dc4796ff26834be2b1aa148e4a9d0761
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dc4796ff26834be2b1aa148e4a9d0761
record_format dspace
spelling oai:doaj.org-article:dc4796ff26834be2b1aa148e4a9d07612021-12-02T20:06:08ZHigh-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.1932-620310.1371/journal.pone.0257324https://doaj.org/article/dc4796ff26834be2b1aa148e4a9d07612021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257324https://doaj.org/toc/1932-6203<h4>Background</h4>High-risk human papillomavirus HPV (HR-HPV) modifies cervical cancer risk in people living with HIV, yet African populations are under-represented. We aimed to compare the frequency, multiplicity and consanguinity of HR-HPVs in HIV-negative and HIV-positive Zimbabwean women.<h4>Methods</h4>This was a cross-sectional study consisting of women with histologically confirmed cervical cancer attending Parirenyatwa Group of Hospitals in Harare, Zimbabwe. Information on HIV status was also collected for comparative analysis. Genomic DNA was extracted from 258 formalin fixed paraffin embedded tumour tissue samples, and analysed for 14 HR-HPV genotypes. Data was analysed using Graphpad Prism and STATA.<h4>Results</h4>Forty-five percent of the cohort was HIV-positive, with a median age of 51 (IQR = 42-62) years. HR-HPV positivity was detected in 96% of biospecimens analysed. HPV16 (48%), was the most prevalent genotype, followed by HPV35 (26%), HPV18 (25%), HPV58 (11%) and HPV33 (10%), irrespective of HIV status. One third of the cohort harboured a single HPV infection, and HPV16 (41%), HPV18 (21%) and HPV35 (21%) were the most prevalent. HIV status did not influence the prevalence and rate of multiple HPV infections (p>0.05). We reported significant (p<0.05) consanguinity of HPV16/18 (OR = 0.3; 95% CI = 0.1-0.9), HPV16/33 (OR = 0.3; 95% CI = 0.1-1.0), HPV16/35 (OR = 3.3; 95% CI = 2.0-6.0), HPV35/51 (OR = 6.0; 95%CI = 1.8-15.0); HPV39/51 (OR = 6.4; 95% CI = 1.8-15), HPV31/52 (OR = 6.2; 95% CI = 1.8-15), HPV39/56 (OR = 11 95% CI = 8-12), HPV59/68 (OR = 8.2; 95% CI = 5.3-12.4), HPV66/68 (OR = 7; 95% CI = 2.4-13.5), independent of age and HIV status.<h4>Conclusion</h4>We found that HIV does not influence the frequency, multiplicity and consanguinity of HR-HPV in cervical cancer. For the first time, we report high prevalence of HPV35 among women with confirmed cervical cancer in Zimbabwe, providing additional evidence of HPV diversity in sub-Saharan Africa. The data obtained here probes the need for larger prospective studies to further elucidate HPV diversity and possibility of selective pressure on genotypes.Oppah KuguyoRacheal S Dube MandishoraNicholas Ekow ThomfordRudo Makunike-MutasaCharles F B NhachiAlice MatimbaCollet DandaraPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0257324 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Oppah Kuguyo
Racheal S Dube Mandishora
Nicholas Ekow Thomford
Rudo Makunike-Mutasa
Charles F B Nhachi
Alice Matimba
Collet Dandara
High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
description <h4>Background</h4>High-risk human papillomavirus HPV (HR-HPV) modifies cervical cancer risk in people living with HIV, yet African populations are under-represented. We aimed to compare the frequency, multiplicity and consanguinity of HR-HPVs in HIV-negative and HIV-positive Zimbabwean women.<h4>Methods</h4>This was a cross-sectional study consisting of women with histologically confirmed cervical cancer attending Parirenyatwa Group of Hospitals in Harare, Zimbabwe. Information on HIV status was also collected for comparative analysis. Genomic DNA was extracted from 258 formalin fixed paraffin embedded tumour tissue samples, and analysed for 14 HR-HPV genotypes. Data was analysed using Graphpad Prism and STATA.<h4>Results</h4>Forty-five percent of the cohort was HIV-positive, with a median age of 51 (IQR = 42-62) years. HR-HPV positivity was detected in 96% of biospecimens analysed. HPV16 (48%), was the most prevalent genotype, followed by HPV35 (26%), HPV18 (25%), HPV58 (11%) and HPV33 (10%), irrespective of HIV status. One third of the cohort harboured a single HPV infection, and HPV16 (41%), HPV18 (21%) and HPV35 (21%) were the most prevalent. HIV status did not influence the prevalence and rate of multiple HPV infections (p>0.05). We reported significant (p<0.05) consanguinity of HPV16/18 (OR = 0.3; 95% CI = 0.1-0.9), HPV16/33 (OR = 0.3; 95% CI = 0.1-1.0), HPV16/35 (OR = 3.3; 95% CI = 2.0-6.0), HPV35/51 (OR = 6.0; 95%CI = 1.8-15.0); HPV39/51 (OR = 6.4; 95% CI = 1.8-15), HPV31/52 (OR = 6.2; 95% CI = 1.8-15), HPV39/56 (OR = 11 95% CI = 8-12), HPV59/68 (OR = 8.2; 95% CI = 5.3-12.4), HPV66/68 (OR = 7; 95% CI = 2.4-13.5), independent of age and HIV status.<h4>Conclusion</h4>We found that HIV does not influence the frequency, multiplicity and consanguinity of HR-HPV in cervical cancer. For the first time, we report high prevalence of HPV35 among women with confirmed cervical cancer in Zimbabwe, providing additional evidence of HPV diversity in sub-Saharan Africa. The data obtained here probes the need for larger prospective studies to further elucidate HPV diversity and possibility of selective pressure on genotypes.
format article
author Oppah Kuguyo
Racheal S Dube Mandishora
Nicholas Ekow Thomford
Rudo Makunike-Mutasa
Charles F B Nhachi
Alice Matimba
Collet Dandara
author_facet Oppah Kuguyo
Racheal S Dube Mandishora
Nicholas Ekow Thomford
Rudo Makunike-Mutasa
Charles F B Nhachi
Alice Matimba
Collet Dandara
author_sort Oppah Kuguyo
title High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
title_short High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
title_full High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
title_fullStr High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
title_full_unstemmed High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
title_sort high-risk hpv genotypes in zimbabwean women with cervical cancer: comparative analyses between hiv-negative and hiv-positive women.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/dc4796ff26834be2b1aa148e4a9d0761
work_keys_str_mv AT oppahkuguyo highriskhpvgenotypesinzimbabweanwomenwithcervicalcancercomparativeanalysesbetweenhivnegativeandhivpositivewomen
AT rachealsdubemandishora highriskhpvgenotypesinzimbabweanwomenwithcervicalcancercomparativeanalysesbetweenhivnegativeandhivpositivewomen
AT nicholasekowthomford highriskhpvgenotypesinzimbabweanwomenwithcervicalcancercomparativeanalysesbetweenhivnegativeandhivpositivewomen
AT rudomakunikemutasa highriskhpvgenotypesinzimbabweanwomenwithcervicalcancercomparativeanalysesbetweenhivnegativeandhivpositivewomen
AT charlesfbnhachi highriskhpvgenotypesinzimbabweanwomenwithcervicalcancercomparativeanalysesbetweenhivnegativeandhivpositivewomen
AT alicematimba highriskhpvgenotypesinzimbabweanwomenwithcervicalcancercomparativeanalysesbetweenhivnegativeandhivpositivewomen
AT colletdandara highriskhpvgenotypesinzimbabweanwomenwithcervicalcancercomparativeanalysesbetweenhivnegativeandhivpositivewomen
_version_ 1718375454873747456